The first pathways understood to constitute the mechanism underlying the observed effect of the TubA and cyclo on U87-MG cell viability was MAPK/ERK, essential for cell proliferation and transformation [40], and PI3K/Akt, which is often hyperactivated in GBM and responsible for cell survival and drug resistance [41]. The gene discussed is AKT1; the disease is glioblastoma.